Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Melanoma × Fulvestrant × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 120 Neoplasm Metastasis 15 Advanced Breast Cancer 7 Ovarian Neoplasms 6 Neoplasms 5 Breast Cancer Metastatic 5 Prostatic Neoplasms 4 Endometrial Neoplasms 4 Hereditary Sensory and Autonomic Neuropathies 3 Recurrence 2 Lung Neoplasms 2 Hyperglycemia 2 Estrogen Receptor-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Squamous Cell Carcinoma of Head and Neck 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Endometrial Stromal 1 Salivary Gland Neoplasms 1 Recurrent Uterine Corpus Carcinoma 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Malignant Neoplasms of Female Genital Organs 1 Locoregional Recurrence 1 Liposarcoma 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Carcinoma 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Ipilimumab 90 Nivolumab 86 pembrolizumab 79 aldesleukin 62 Cyclophosphamide 40 Interleukin-2 38 trametinib 28 dabrafenib 27 fludarabine phosphate 26 Dacarbazine 26 Temozolomide 25 Vemurafenib 24 incomplete Freund's adjuvant 23 Bevacizumab 23 sargramostim 21 fludarabine 21 Radiosurgery 19 binimetinib 17 encorafenib 16 cobimetinib 15 Paclitaxel 15 Carboplatin 13 atezolizumab 12 Radiotherapy 12 Sorafenib 11 Biopsy 11 talimogene laherparepvec 10 montanide ISA 51 10 MART-1 Antigen 10 CTLA-4 Antigen 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340619 2026-01-14

EPIBREAST

UNICANCER

Phase 2 Not yet recruiting

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡